Department of Ophthalmology, The University of New South Wales and Prince of Wales Hospital, Randwick, New South Wales, Australia.
Cornea. 2011 Jan;30(1):7-10. doi: 10.1097/ICO.0b013e3181da58a4.
To assess the role of hyperbaric oxygen therapy (HBOT) in the management of recurrent pterygium.
Thirty-nine eyes with recurrent pterygium were treated with surgical excision and limbal conjunctival autograft, followed by a course of HBOT. Patients were followed for development of recurrence.
Of the 39 eyes, 18 had a known history of exposure to beta radiation or mitomycin C. The mean duration of follow-up in this group was 23.1 months. A single recurrence was noted in this group. For the remaining 21 eyes, the mean duration of follow-up was 19.4 months. No recurrences were recorded in this group. No significant complications from HBOT were recorded.
The use of HBOT together with excision and limbal conjunctival autograft for recurrent pterygium is associated with a low recurrence rate. Adjuvant HBOT should be considered in the surgical management of recurrent pterygium.
评估高压氧治疗（HBOT）在复发性翼状胬肉治疗中的作用。
39 只复发性翼状胬肉眼接受手术切除和角膜缘结膜自体移植，随后进行 HBOT 治疗。对患者进行随访以观察复发情况。
18 只眼有已知的β射线或丝裂霉素 C 暴露史。该组的平均随访时间为 23.1 个月。该组中有 1 只眼出现单一复发。对于其余 21 只眼，平均随访时间为 19.4 个月。该组无复发。HBOT 无明显并发症。
对于复发性翼状胬肉，联合使用切除和角膜缘结膜自体移植以及 HBOT 治疗，复发率较低。在复发性翼状胬肉的手术治疗中应考虑辅助 HBOT。
